Page last updated: 2024-11-03

propofol and Aggressive Systemic Mastocytosis

propofol has been researched along with Aggressive Systemic Mastocytosis in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ulbrich, F1
Engelstädter, H1
Wittau, N1
Steinmann, D1

Other Studies

1 other study available for propofol and Aggressive Systemic Mastocytosis

ArticleYear
Anaesthetic management of emergency caesarean section in a parturient with systemic mastocytosis.
    International journal of obstetric anesthesia, 2013, Volume: 22, Issue:3

    Topics: Abdominal Pain; Adult; Anesthesia, General; Anesthesia, Obstetrical; Anesthetics, Intravenous; Cesar

2013